Digital Adherence Technologies and Differentiated Care forTuberculosis Treatment and Their Acceptability Among PersonsWith Tuberculosis, Health Care Workers, and Key Informants inthe Philippines:Qualitative Interview Study

被引:2
作者
Leung, Chung Lam [1 ]
Alacapa, Jason [2 ]
Tasca, Bianca Goncalves [1 ]
Villanueva, Andre Daniel [2 ]
Masulit, Saniata [2 ]
Ignacio, Marvin Louie [2 ]
Uy, Kathleen Nicole [2 ]
Pell, Christopher [1 ]
van Kalmthout, Kristian [1 ]
Powers, Rachel [1 ]
Fielding, Katherine [3 ,4 ]
Jerene, Degu [1 ]
机构
[1] KNCV TB Fdn, Maanweg 174, NL-2516AB The Hague, Netherlands
[2] KNCV TB Fdn Philippines, Manila, Philippines
[3] London Sch Hyg & Trop Med, TB Ctr, London, England
[4] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Infect Dis Epidemiol, London, England
来源
JMIR HUMAN FACTORS | 2024年 / 11卷
关键词
tuberculosis; digital adherence technologies; implementation; acceptability; qualitative research; Philippines; digital health; tuberculosis treatment; support strategy; support; medication adherence; health care workers; interview; interviews; user; userprivacy; privacy; digital adherence;
D O I
10.2196/54117
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Digital adherence technologies (DATs) are being studied to determine their potential to support tuberculosis (TB)treatment and address the shortcomings of directly observed therapy. Previous research has shown inconclusive results on whetherDATs can enhance medication adherence among persons with TB.Objective: This study aims to understand the acceptability of DATs, namely, medication labels and smart pillboxes, amongpersons with TB, health care workers (HCWs), and key informants (KIs) in the Philippines. The objective is to gain valuableinsights that can inform the design and implementation of DATs in the Southeast Asian region, which meet the needs andpreferences of end users.Methods: Persons with TB, HCWs, and KIs were recruited from intervention facilities to participate in in-depth interviewsconducted between March 2022 and January 2023. These interviews were transcribed and translated into English. A thematicanalysis was carried out using NVivo software (Lumivero) to identify and analyze themes. Themes were then structured withina modified social-ecological model.Results: A total of 25 persons with drug-sensitive TB and 20 HCWs or KIs were interviewed. Both groups emphasized thatusers'technology literacy level, financial conditions, and motivation to be cured determined how they interacted with the DAT.They also acknowledged that DATs helped foster their relationship with HCWs and enabled efficient treatment support. Concerningtechnology, persons with TB found DATs easy to use and able to reduce clinic visits. HCWs mentioned that DATs added to theirworkload but also allowed them to support users who missed doses. However, both groups experienced technical challenges withDATs. Regarding program implementation, users appreciated the clear explanations and demonstrations provided by HCWs.Yet, some users reported inconsistencies between DAT settings and the information provided. HCWs stressed the importance ofcomprehensive training and sufficient resources for effective program implementation in the future. At the community level, bothgroups noted that DATs and program design protected users'privacy and reduced the risk of stigma. Finally, users and HCWsshared various contextual factors that influenced their experience with DAT, including infrastructure challenges and the impactof the COVID-19 pandemic
引用
收藏
页数:12
相关论文
共 37 条
  • [1] A randomised controlled trial to evaluate a medication monitoring system for TB treatment
    Acosta, J.
    Flores, P.
    Alarcon, M.
    Grande-Ortiz, M.
    Moreno-Exebio, L.
    Puyen, Z. M.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2022, 26 (01) : 44 - +
  • [2] [Anonymous], 2021, NTP Manual of Procedures, V6
  • [3] [Anonymous], 2023, Tuberculosis profile: Philippines
  • [4] SMS reminders to improve adherence and cure of tuberculosis patients in Cameroon (TB-SMS Cameroon): a randomised controlled trial
    Bediang, Georges
    Stoll, Beat
    Elia, Nadia
    Abena, Jean-Louis
    Geissbuhler, Antoine
    [J]. BMC PUBLIC HEALTH, 2018, 18
  • [5] Can digital adherence technologies reduce inequity in tuberculosis treatment success? Evidence from a randomised controlled trial
    Boutilier, Justin J.
    Yoeli, Erez
    Rathauser, Jon
    Owiti, Philip
    Subbaraman, Ramnath
    Jonasson, Jonas Oddur
    [J]. BMJ GLOBAL HEALTH, 2022, 7 (12):
  • [6] Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1080/14780887.2020.1769238, 10.1191/1478088706qp063oa]
  • [7] Digital adherence technology for tuberculosis treatment supervision: A stepped-wedge cluster-randomized trial in Uganda
    Cattamanchi, Adithya
    Crowder, Rebecca
    Kityamuwesi, Alex
    Kiwanuka, Noah
    Lamunu, Maureen
    Namale, Catherine
    Tinka, Lynn Kunihira
    Nakate, Agnes Sanyu
    Ggita, Joseph
    Turimumahoro, Patricia
    Babirye, Diana
    Oyuku, Denis
    Berger, Christopher
    Tucker, Austin
    Patel, Devika
    Sammann, Amanda
    Stavia, Turyahabwe
    Dowdy, David
    Katamba, Achilles
    [J]. PLOS MEDICINE, 2021, 18 (05)
  • [8] Perceptions of stigma among pulmonary tuberculosis patients in Thailand, and the links to delays in accessing healthcare
    Chaychoowong, Kampanart
    Watson, Roger
    Barrett, David, I
    [J]. JOURNAL OF INFECTION PREVENTION, 2023, 24 (02) : 77 - 82
  • [9] Assessing the Consequences of Stigma for Tuberculosis Patients in Urban Zambia
    Cremers, Anne Lia
    de laat, Myrthe Manon
    Kapata, Nathan
    Gerrets, Rene
    Klipstein-Grobusch, Kerstin
    Grobusch, Martin Peter
    [J]. PLOS ONE, 2015, 10 (03):
  • [10] Community tuberculosis care through "TB clubs" in rural North Ethiopia
    Demissie, M
    Getahun, H
    Lindtjorn, B
    [J]. SOCIAL SCIENCE & MEDICINE, 2003, 56 (10) : 2009 - 2018